Does BEVACIZUMAB Cause Therapy partial responder? 632 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 632 reports of Therapy partial responder have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.8% of all adverse event reports for BEVACIZUMAB.
632
Reports of Therapy partial responder with BEVACIZUMAB
0.8%
of all BEVACIZUMAB reports
221
Deaths
64
Hospitalizations
How Dangerous Is Therapy partial responder From BEVACIZUMAB?
Of the 632 reports, 221 (35.0%) resulted in death, 64 (10.1%) required hospitalization, and 35 (5.5%) were considered life-threatening.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 632 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which BEVACIZUMAB Alternatives Have Lower Therapy partial responder Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ